Sanofi (SNY) Non Operating Income (2009 - 2016)

Sanofi has disclosed Non Operating Income across 8 years of filings, most recently posting -$430.8 million for Q4 2016.

• Non Operating Income for Q4 2016 came in at -$430.8 million, down 3.16% year-over-year; the trailing twelve-month figure through Dec 2016 was -$1.1 billion (down 42.67% YoY), and the FY2016 annual result was -$441.7 million, down 1.96% from the prior year.
• Non Operating Income came in at -$430.8 million for Q4 2016 at Sanofi, down from -$130.2 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of -$104.1 million in Q1 2014 to a low of -$430.8 million in Q4 2016.
• The 5-year median for Non Operating Income is -$165.9 million (2012), against an average of -$187.3 million.
• Across the five-year window, Non Operating Income surged 45.4% in 2013 and sank 142.13% in 2015, its largest moves.
• Sanofi's Non Operating Income stood at -$256.8 million in 2012, then soared by 45.4% to -$140.2 million in 2013, then decreased by 23.03% to -$172.5 million in 2014, then plunged by 142.13% to -$417.6 million in 2015, then slipped by 3.16% to -$430.8 million in 2016.
• The last three Non Operating Income figures came in at -$430.8 million (Q4 2016), -$130.2 million (Q1 2016), and -$417.6 million (Q4 2015), per Business Quant data.